HR Execs on the Move


 
Lark Health is the leading virtual chronic disease management and prevention platform. Lark helps people stay healthy and in control of their conditions, such as Diabetes, Prediabetes, Cardiovascular Disease, and Anxiety from the comfort of their homes.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.lark.com
  • 2570 El Camino Real
    Mountain View, CA USA 94040
  • Phone: 650.381.9225

Executives

Name Title Contact Details
Shannon Marques
Senior Vice President of Revenue Operations Profile
Susan Singer
VP, Product Management and Technology Operations Profile
Jeff Zira
Co-founder (CTO / VP Product) Profile
Iveta Brigis
Vice President of Human Resources Profile
Mitchel Harad
Vice President of Consumer Marketing Profile

Similar Companies

VTS Medical Systems

VTS Medical Systems is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Buck Institute

The Buck Institute is committed to providing a strong benefits package as part of its total compensation program.

Rice Home Medical

Rice Home Medical is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Iberia Medical Center

Iberia Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Iberia Medical Center is based in New Iberia, LA. You can find more information on Iberia Medical Center at www.iberiamedicalcenter.com

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.